Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibition by using SiRNA induce apoptosis, reduce cell proliferation and migration invitro
PLoS ONE, ISSN: 1932-6203, Vol: 10, Issue: 3, Page: e0115651
2015
- 44Citations
- 44Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations44
- Citation Indexes44
- 44
- CrossRef13
- Captures44
- Readers44
- 44
Article Description
Telomere binding factors viz. TRF1 and TRF2 are a part of sheltrin complex that are present exclusively at the ends of chromosomes. These factors play an important role in maintaining chromosomal integrity at the ends. However, their status and role are not clear in renal cell carcinoma (RCC). Therefore, the present study was conducted to evaluate TRF1 and TRF2 expressions in RCC tissues. Further, the role of these factors involved in tumorigenesis was elucidated by gene silencing using siRNA in RCC cell line (A498). The present study documented a significant over-expression of TRF1 (P = 0.005) and TRF2 (P = 0.0048) mRNAs by real time PCR in RCC tissues as compared with adjacent normal kidney tissues. Immunohistochemistry studies also revealed higher expression of TRF1 and TRF2 proteins in RCC. Moreover, TRF1 or TRF2 gene silencing using siRNA showed marked reduction in proliferation of RCC cells (P = 0.000). Further, significantly induced cell cycle arrest (P = 0.000) and apoptosis of RCC cells (P = 0.000) was documented upon TRF1 or TRF2 gene silencing. Henceforth, the results deduce that TRF1 or TRF2 inhibitions play an important role in the induction of apoptosis in A498 cells, which may serve as a potential therapeutic target in RCC.
Bibliographic Details
10.1371/journal.pone.0115651; 10.1371/journal.pone.0115651.g003; 10.1371/journal.pone.0115651.g005; 10.1371/journal.pone.0115651.g004; 10.1371/journal.pone.0115651.g001; 10.1371/journal.pone.0115651.g002
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84923875913&origin=inward; http://dx.doi.org/10.1371/journal.pone.0115651; http://www.ncbi.nlm.nih.gov/pubmed/25730259; https://dx.plos.org/10.1371/journal.pone.0115651; https://dx.plos.org/10.1371/journal.pone.0115651.g003; http://dx.doi.org/10.1371/journal.pone.0115651.g003; https://dx.plos.org/10.1371/journal.pone.0115651.g005; http://dx.doi.org/10.1371/journal.pone.0115651.g005; https://dx.plos.org/10.1371/journal.pone.0115651.g004; http://dx.doi.org/10.1371/journal.pone.0115651.g004; https://dx.plos.org/10.1371/journal.pone.0115651.g001; http://dx.doi.org/10.1371/journal.pone.0115651.g001; https://dx.plos.org/10.1371/journal.pone.0115651.g002; http://dx.doi.org/10.1371/journal.pone.0115651.g002; https://dx.doi.org/10.1371/journal.pone.0115651.g003; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0115651.g003; https://dx.doi.org/10.1371/journal.pone.0115651.g002; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0115651.g002; https://dx.doi.org/10.1371/journal.pone.0115651.g001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0115651.g001; https://dx.doi.org/10.1371/journal.pone.0115651.g004; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0115651.g004; https://dx.doi.org/10.1371/journal.pone.0115651; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0115651; https://dx.doi.org/10.1371/journal.pone.0115651.g005; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0115651.g005; http://www.plosone.org/article/metrics/info:doi/10.1371/journal.pone.0115651; http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0115651&type=printable; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0115651; https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0115651&type=printable; http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0115651; http://dx.plos.org/10.1371/journal.pone.0115651.g002; http://dx.plos.org/10.1371/journal.pone.0115651.g005; http://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0115651; http://dx.plos.org/10.1371/journal.pone.0115651.g004; http://dx.plos.org/10.1371/journal.pone.0115651.g001; http://dx.plos.org/10.1371/journal.pone.0115651.g003; http://dx.plos.org/10.1371/journal.pone.0115651
Public Library of Science (PLoS)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know